Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials

Mario Balducci; A. Fiorentino; Alba Fiorentino; Pasquale De Bonis; Silvia Chiesa; Annunziato Mangiola; Gian Carlo Mattiucci; Giuseppe Roberto D'Agostino; Vincenzo Frascino; Giovanna Mantini; Anna Rita Alitto; Cesare Colosimo; Carmelo Anile; Vincenzo Valentini

doi:10.1007/s00066-013-0410-6

Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials

Mario Balducci
, A. Fiorentino
, Alba Fiorentino
, Pasquale De Bonis
, Silvia Chiesa
, Annunziato Mangiola
, Gian Carlo Mattiucci
, Giuseppe Roberto D'Agostino
, Vincenzo Frascino
, Giovanna Mantini
, Anna Rita Alitto
, Cesare Colosimo
, Carmelo Anile
, Vincenzo Valentini

IRCCS Centro di riferimento oncologico della Basilicata - Rionero in Vulture (PZ)

Risultato della ricerca: Contributo in rivista › Articolo

8 Citazioni (Scopus)

Abstract

To investigate the impact of nonstandard concomitant temozolomide (TMZ) administration in two prospective phase II studies for glioblastoma (GBM).

Lingua originale	Inglese
pagine (da-a)	926-931
Numero di pagine	6
Rivista	Strahlentherapie und Onkologie
Volume	189
DOI	https://doi.org/10.1007/s00066-013-0410-6
Stato di pubblicazione	Pubblicato - 2013

Keywords

Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating
Brain Neoplasms
Chemoradiotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Combined Modality Therapy
Dacarbazine
Disease-Free Survival
Glioblastoma
Humans
Italy
Middle Aged
Prevalence
Prospective Studies
Risk Assessment
Survival Rate
Treatment Outcome
Young Adult

Accesso al documento

10.1007/s00066-013-0410-6

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Balducci, M., Fiorentino, A., Fiorentino, A., De Bonis, P., Chiesa, S., Mangiola, A., Mattiucci, G. C., D'Agostino, G. R., Frascino, V., Mantini, G., Alitto, A. R., Colosimo, C., Anile, C., & Valentini, V. (2013). Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials. Strahlentherapie und Onkologie, 189, 926-931. https://doi.org/10.1007/s00066-013-0410-6

@article{6214b3897c604980876c3433d9c9596e,

title = "Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials",

abstract = "To investigate the impact of nonstandard concomitant temozolomide (TMZ) administration in two prospective phase II studies for glioblastoma (GBM).",

keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating, Brain Neoplasms, Chemoradiotherapy, Adjuvant, Clinical Trials, Phase II as Topic, Combined Modality Therapy, Dacarbazine, Disease-Free Survival, Glioblastoma, Humans, Italy, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Survival Rate, Treatment Outcome, Young Adult, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating, Brain Neoplasms, Chemoradiotherapy, Adjuvant, Clinical Trials, Phase II as Topic, Combined Modality Therapy, Dacarbazine, Disease-Free Survival, Glioblastoma, Humans, Italy, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Survival Rate, Treatment Outcome, Young Adult",

author = "Mario Balducci and A. Fiorentino and Alba Fiorentino and \{De Bonis\}, Pasquale and Silvia Chiesa and Annunziato Mangiola and Mattiucci, \{Gian Carlo\} and D'Agostino, \{Giuseppe Roberto\} and Vincenzo Frascino and Giovanna Mantini and Alitto, \{Anna Rita\} and Cesare Colosimo and Carmelo Anile and Vincenzo Valentini",

year = "2013",

doi = "10.1007/s00066-013-0410-6",

language = "English",

volume = "189",

pages = "926--931",

journal = "Strahlentherapie und Onkologie",

issn = "0179-7158",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Balducci, M, Fiorentino, A, Fiorentino, A, De Bonis, P, Chiesa, S, Mangiola, A, Mattiucci, GC, D'Agostino, GR, Frascino, V, Mantini, G, Alitto, AR, Colosimo, C, Anile, C & Valentini, V 2013, 'Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials', Strahlentherapie und Onkologie, vol. 189, pagg. 926-931. https://doi.org/10.1007/s00066-013-0410-6

TY - JOUR

T1 - Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials

AU - Balducci, Mario

AU - Fiorentino, A.

AU - Fiorentino, Alba

AU - De Bonis, Pasquale

AU - Chiesa, Silvia

AU - Mangiola, Annunziato

AU - Mattiucci, Gian Carlo

AU - D'Agostino, Giuseppe Roberto

AU - Frascino, Vincenzo

AU - Mantini, Giovanna

AU - Alitto, Anna Rita

AU - Colosimo, Cesare

AU - Anile, Carmelo

AU - Valentini, Vincenzo

PY - 2013

Y1 - 2013

N2 - To investigate the impact of nonstandard concomitant temozolomide (TMZ) administration in two prospective phase II studies for glioblastoma (GBM).

AB - To investigate the impact of nonstandard concomitant temozolomide (TMZ) administration in two prospective phase II studies for glioblastoma (GBM).

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Agents, Alkylating

KW - Brain Neoplasms

KW - Chemoradiotherapy, Adjuvant

KW - Clinical Trials, Phase II as Topic

KW - Combined Modality Therapy

KW - Dacarbazine

KW - Disease-Free Survival

KW - Glioblastoma

KW - Humans

KW - Italy

KW - Middle Aged

KW - Prevalence

KW - Prospective Studies

KW - Risk Assessment

KW - Survival Rate

KW - Treatment Outcome

KW - Young Adult

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Agents, Alkylating

KW - Brain Neoplasms

KW - Chemoradiotherapy, Adjuvant

KW - Clinical Trials, Phase II as Topic

KW - Combined Modality Therapy

KW - Dacarbazine

KW - Disease-Free Survival

KW - Glioblastoma

KW - Humans

KW - Italy

KW - Middle Aged

KW - Prevalence

KW - Prospective Studies

KW - Risk Assessment

KW - Survival Rate

KW - Treatment Outcome

KW - Young Adult

UR - http://hdl.handle.net/10807/52018

U2 - 10.1007/s00066-013-0410-6

DO - 10.1007/s00066-013-0410-6

M3 - Article

SN - 0179-7158

VL - 189

SP - 926

EP - 931

JO - Strahlentherapie und Onkologie

JF - Strahlentherapie und Onkologie

ER -

Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo